Transhiatal esophagectomy in a high volume institution

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Davies, Andrew R ^a   Forshaw, Matthew J ^a   Khan, Aadil A ^a   Noorani, Alia S ^a   Patel, Vanash M ^a   Strauss, Dirk C ^a   Mason, Robert C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA COLLECTION METHOD; DEEP VEIN THROMBOSIS; ESOPHAGUS DISEASE; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LENGTH OF STAY; LOWER ESOPHAGUS SPHINCTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREOPERATIVE EVALUATION; RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY TRACT DISEASE; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; URINE INCONTINENCE; WOUND INFECTION; ADJUVANT THERAPY; ADULT; ESOPHAGUS TUMOR; METHODOLOGY; MIDDLE AGED; REGISTER; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 51649091934     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-88     Document Type: Article

References (40)

1. Blot WJ Devesa SS Kneller RW Fraumeni JF Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265:1287-1289. 10.1001/jama.265.10.1287 1995976
2. Allum WH Griffin SM Watson A Colin-Jones D: Guidelines for the management of oesophageal and gastric cancer. Gut 2002 50(Suppl V):v1-v23.
3. Cunningham D Allum WH Stenning SP Thompson JN Velde Van de CJ Nicolson M Scarffe JH Lofts FJ Falk SJ Iveson TJ Smith DB Langley RE Verma M Weeden S Chua YJ: MAGIC Trial Participants Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355:11-20. 10.1056/NEJMoa055531 16822992
4. Lin J Iannettoni MD: Transhiatal esophagectomy. Surg Clin North Am 2005, 85(3):593-610. 10.1016/j.suc.2005.01.009 15927654
5. Orringer MB Marshall B Iannettoni MD: Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg 2001, 25(2):196-203. 10.1007/s002680020019 11338022
6. Siewert JR Feith M Stein HJ: Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: Relevance of a topographic-anatomic subclassification. J Surg Oncol 2005, 90(3):139-146. 10.1002/jso.20218 15895452
7. The Royal College of Pathologists: Standards and datasets for reporting cancers http://www.rcpath.org/index.asp?PageID=254 [cited 10 May 2007]
8. Siewert JR Stein HJ: Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998, 85:1457-1459. 10.1046/ j.1365-2168.1998.00940.x 9823902
9. American Joint Committee on Cancer: AJCC Cancer Staging Handbook Philadelphia, PA: Lippincott-Raven 2002
10. Kaplan EL Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-462. 10.2307/2281868
11. Owens WD Felts JA Spitznagel EL Jr: ASA physical status classifications. A study of consistency of ratings. Anesthesiology 1978, 49:239-243. 10.1097/00000542-197810000-00003 697077
12. Orringer MB Marshall B Iannettoni MD: Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999, 230:392-400. 1420884 10493486 10.1097/00000658-199909000-00012
13. van Sandick JW van Lanschot JJ ten Kate FJ Tijssen JG Obertop H: Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg 2002, 194:28-36. 10.1016/ S1072-7515(01)01119-X 11803954
14. McCulloch P Ward J Tekkis PP: Mortality and morbidity in gastro-oesophageal cancer surgery: Initial results of ASCOT multicentre prospective cohort study. BMJ 2003, 327:1192-7. 274052 14630753 10.1136/ bmj.327.7425.1192
15. Sauvanet A Mariette C Thomas P Lozac'h P Segol P Tiret E Delpero JR Collet D Leborgne J Pradere B Bourgeon A Triboulet JP: Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: Predictive factors. J Am Coll Surg 2005, 201(2):253-62. 10.1016/j.jamcollsurg.2005.02.002 16038824
16. Dimick JB Wainess RM Upchurch GR Jr Ianettoni MD Orringer MB: National trends in outcomes for esophageal resection. Ann Thorac Surg 2005, 79:212-8. 10.1016/j.athoracsur.2004.06.044 15620945
17. Van Lanschot JJ Hulscher JB Buskens CJ Tilanus HW ten Kate FJ Obertop H: Hospital volume and hospital mortality for esophagectomy. Cancer 2001, 91:1574-8. 10.1002/ 1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2 11301408
18. Metzger R Bollschweiler E Vallbohmer D Maish M DeMeester TR Holscher AH: High volume centers for esophagectomy: What is the number needed to achieve low postoperative mortality?. Dis Esophagus 2004, 17:310-314. 10.1111/j.1442-2050.2004.00431.x 15569369
19. Al-Sarira AA David G Willmott S Slavin JP Deakin M Corless DJ: Oesophagectomy practice and outcomes in England. Br J Surg 2007, 94(5):585-91. 10.1002/bjs.5805 17443856
20. Altorki N Skinner D: Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 2001, 234:581-587. 1422081 11685019 10.1097/00000658-200111000-00001
21. Portale G Hagen JA Peters JH Chan LS DeMeester SR Gandamihardja TA DeMeester TR: Modern 5-year survival of resectable esophageal adenocarcinoma: Single institution experience with 263 patients. J Am Coll Surg 2006, 202(4):588-96. discussion 596-8 10.1016/ j.jamcollsurg.2005.12.022 16571425
22. Hagen JA DeMeester SR Peters JH Chandrasoma P DeMeester TR: Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001, 234:520-530. discussion 530-531 1422075 11573045 10.1097/00000658-200110000-00011
23. Hulscher JB Tijssen JG Obertop H van Lanschot JJ: Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001, 72:306-313. 10.1016/S0003-4975(00)02570-4 11465217
24. Lerut T Nafteux P Moons J Coosemans W Decker G De Leyn P Van Raemdonck D Ectors N: Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome: A Plea for Adaptation of TNM Classification in Upper-Half Esophageal Carcinoma. Ann Surg 2004, 240(6):962-974. 1356512 15570202 10.1097/01.sla.0000145925.70409.d7
25. Robey-Cafferty SS el-Naggar AK Sahin AA Bruner JM Ro JY Cleary KR: Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol 1991, 95:844-849. 2042594
26. DiMusto PD Orringer MB: Transhiatal esophagectomy for distal and cardia cancers: Implications of a positive gastric margin. Ann Thorac Surg 2007, 83(6):1993-8. 10.1016/j.athoracsur.2006.09.025 17532385
27. Khan OA Fitzgerald JJ Soomro I Beggs FD Morgan WE Duffy JP: Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 88(10):1549-52. 2003 May 19 10.1038/sj.bjc.6600931 12771920
28. Griffiths EA Brummell Z Gorthi G Pritchard SA Welch IM: The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol 2006, 32(4):413-9. 10.1016/ j.ejso.2005.11.024 16504455
29. Sujendran V Wheeler J Baron R Warren BF Maynard N: Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg 2008, 95(2):191-4. 10.1002/bjs.5983 17948302
30. Feith M Stein HJ Siewert JR: Adenocarcinoma of the esophagogastric junction: Surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 2006, 15(4):751-64. 10.1016/j.soc.2006.07.015 17030271
31. Hulscher JB van Sandick JW Tijssen JG Obertop H van Lanschot JJ: The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000, 191:143-148. 10.1016/S1072-7515(00)00349-5 10945357
32. Wayman J Bennett MK Raimes SA Griffin SM: The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 86(8):1223-9. 2002, Apr 22 10.1038/sj.bjc.6600252 11953876
33. Orringer MB Marshall B Chang AC Lee J Pickens A Lau CL: Two thousand Transhiatal esophagectomies; Changing trends, lessons learned. Annals of Surgery 2007, 246(3):363-374. 1959358 17717440 10.1097/ SLA.0b013e31814697f2
34. Hulscher JB van Sandick JW de Boer AG Wijnhoven BP Tijssen JG Fockens P Stalmeier PF ten Kate FJ van Dekken H Obertop H Tilanus HW van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347:1662-1669. 10.1056/NEJMoa022343 12444180
35. Omloo JMT Lagarde SM Hulscher JB Reitsma JB Fockens P van Decken H ten Kate FJ Obertop H Tilanus HW van Lanscho JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five year survival of a Randomized clinical trial. Annals of Surgery 2007, 246:992-1001. 18043101
36. Chang AC Ji K Birkmeyer NJ Orringer MB Birkmeyer JD: Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008, 85(2):424-9. 10.1016/j.athoracsur.2007.10.007 18222237
37. Jamieson GG Mathew G Ludemann R Wayman J Myers JC Devitt PG: Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004, 91(8):943-7. 10.1002/bjs.4596 15286953
38. de Boer AG van Lanschot JJ van Sandick JW Hulscher JB Stalmeier PF de Haes JC Tilanus HW Obertop H Sprangers MA: Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 22, 20:4202-8. 2004 Oct 15 10.1200/JCO.2004.11.102 15483031
39. Gebski V Burmeister B Smithers BM Foo K Zalcberg J Simes J: Australasian Gastro-Intestinal Trials Group Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 2007, 8(3):226-34. 10.1016/ S1470-2045(07)70039-6 17329193
40. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002, 359(9319):1727-1733. 10.1016/S0140-6736(02)08651-8 12049861